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SHARING OF ANTIGENS BETWEEN Plasmodium falciparum AND Anopheles albimanus
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SUMMARY
The presence of common antigens between Plasmodium falciparum and Anopheles albimanus was demonstrated. Different
groups of rabbits were immunized with: crude extract from female An. albimanus (EAaF), red blood cells infected with Plasmodium
falciparum (EPfs), and the SPf66 synthetic malaria vaccine. The rabbit´s polyclonal antibodies were evaluated by ELISA, Multiple
Antigen Blot Assay (MABA), and immunoblotting. All extracts were immunogenic in rabbits according to these three techniques,
when they were evaluated against the homologous antigens. Ten molecules were identified in female mosquitoes and also in P.
falciparum antigens by the autologous sera. The electrophoretic pattern by SDS-PAGE was different for the three antigens evaluated.
Cross-reactions between An. albimanus and P. falciparum were found by ELISA, MABA, and immunoblotting. Anti-P. falciparum
and anti-SPf66 antibodies recognized ten and five components in the EAaF crude extract, respectively. Likewise, immune sera
against female An. albimanus identified four molecules in the P. falciparum extract antigen. As far as we know, this is the first
work that demonstrates shared antigens between anophelines and malaria parasites. This finding could be useful for diagnosis,
vaccines, and the study of physiology of the immune response to malaria.
KEYWORDS: Anopheles albimanus; Plasmodium falciparum; Shared antigens; Cross-reaction; Multiple Antigen Blot Assay
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INTRODUCTION
Several studies have reported that, during the process of co-
evolution, parasites have shared and expressed equivalent molecules
with their hosts. These cross-reactions may probably result from a
process of adaptation of these invertebrates to counteract protective
immunological mechanisms3,4,24.
Specifically, these shared antigens between parasites and their hosts
have been demonstrated among different species of trematodes and
their intermediate hosts8,9,10,16,17,29,45. One of them is tropomyosin, a
protein shared by S. mansoni and its intermediate host Biomphalaria
glabrata20 .
It has been proposed that the presence of common antigens between
some parasites and their hosts would facilitate the search for candidate
vaccines and diagnostic targets, when observing the abundance of
antigenic material that can be obtained from those hosts, as
demonstrated in schistosomiasis. The existence of shared antigens
between Schistosoma and Biomphalaria has been shown by the presence
of anti-Biomphalaria antibodies in experimental animals infected with
the parasite. The opposite has also been demonstrated in animals
immunized with uninfected snails, which have shown anti-Schistosoma
antibodies. Additionally, anti-Biomphalaria antibodies have been found
in infected humans with Schistosoma mansoni1,18,19,22,25,27,33.
Malaria is a vector-borne disease transmitted through the bite of
anopheline mosquitoes, the only genus that transmits human malaria26,47.
In America, the most important species of Anopheles are: An. darlingi,
An. albimanus, An. aquasalis, and An. pseudopunctipennis23. However,
so far, no study has been carried out to determine shared antigens
between Plasmodium and their vectors.
For this reason, the purpose of this research is to identify shared
antigens between An. albimanus and P. falciparum that could have
potential relevance in immunodiagnosis and immunoprophylaxis of
malaria. It is also useful in explaining false positive results observed
against malaria antigens in individuals who were exposed to multiple
anopheline bites. In preliminary studies carried out with humans who
did not have any previous malaric episodes and who come from a non
endemic area in Venezuela, a percentage of seropositivity against
molecules from An. albimanus and P. falciparum crude extracts was
found (unpublished results). The identification of common antigens
between the parasite and its vector could be of value in a multi-target
vaccine (anti-parasite and anti-vector), once the feasibility of anti-
arthropod vaccines is demonstrated11,44.
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MATERIALS AND METHODS
Source of adult An. albimanus mosquitoes: A mosquito colony
from An. albimanus was maintained in the laboratory according to the
methodology described by ZERPA et al.46.
Preparation of An. albimanus crude extract antigen: A crude
anopheline preparation was obtained from female mosquitoes (EAaF)
five to six days old. Female newborn mosquitoes were fed only with
sugar solution until the moment of the extract preparation. None of the
mosquitoes were exposed to a blood meal. These were immobilized
by exposure to a temperature below 0 °C, during 15 min in a freezer.
Afterwards, legs and wings were removed without damaging the
abdomen, thorax and head. Each lot of antigen was prepared with 25
mosquitoes and homogenized in 0.5 mL of saline solution 0.85% (w/
v) with a homogenizer (Potter Eveljhan), through 30 cycles as described
by ALGER & CABRERA2 and SUTHERLAND & EWEN38. After the
homogenization, the mosquito extract was sonicated in a Braun-Sonic
1510 (B. Braun Melsungen AG) at 100 watts, using six cycles of one
min each at 5 ºC. The sonicated sample was centrifuged at 4,960 g for
one h at 5 °C. Finally, one extract was obtained by mixing all the
preparations from the same colony of mosquitoes, and then, only the
supernatant was used as antigen.
Preparation of Plasmodium falciparum antigen: P. falciparum
(FCB2 strain) parasites were obtained from continuous in vitro culture
with a parasitemia of 10% to 12%, according to the methodology of
TRAGER & JENSEN41. Parasites were concentrated by a discontinuous
gradient of Percoll: 75% (v/v), 60% (v/v), 40% (v/v) as described by
KRAMER et al.28 and RIVADENEIRA et al.35. The layer of cells
enriched with parasitized red blood cells (PRBC) was centrifuged at
861 g for 15 min at 4 ºC. Three types of P. falciparum antigens were
obtained: (a) Crude extract (EPfd) obtained with detergent: PRBC were
treated with saponin solution at 0.2% (w/v) in a 7:1 ratio, strongly
stirred during 20 s and centrifuged at 1,240 g for 10 min. After two
washes in PBS at 1,240 g X 10 min, the pellet containing parasites and
the ghost red blood cells were collected. The PRBC lysis was completed
by treating with a buffer solution, containing SDS at 10% (v/v), EDTA
1M, PMSF 100 mM or 300 µL Protease Inhibitor Cocktails (Sigma, P
2714), in a 7:1 ratio, and thereafter by shaking with a vortex at maximum
speed during five min. Finally, the homogenate was centrifuged at
15,800 g in a microcentrifuge for 20 min, discarding the pellet and
keeping the supernatant according to SALCEDO et al.37. This extract
was used for the assays. (b) Crude extract obtained by sonication (EPfs):
The PRBC was resuspended in 1 mL of PBS-Dulbecco and sonicated
in a Braun-Sonic 1510 (B. Braun Melsungen AG) at 100 watts by six
cycles of one min each at 5 ºC. Thereafter, it was centrifuged at 12,000
g for 30 min, discarding the pellet and keeping the supernatant. Only
one extract was prepared by this methodology and used as antigen. (c)
Preparation of culture Supernatant (Spt) antigen: In vitro culture of P.
falciparum was centrifuged at 1,240 g for 10 min at 4 ºC, and the
supernatant obtained was used as the control antigen in MABA. Protein
concentration of the different antigen preparations was quantified
following the BRADFORD5 method.
 Immunization of rabbits: Three months old New Zealand rabbits
were injected subcutaneously with 0.5 mg of SPf66 vaccine, 0.5 mg of
EPfs, or 1 mg of EAaF extracts, emulsified in Complete Freund’s
Adjuvant (CFA) for the first dose and with Incomplete Freund’s
Adjuvant (IFA) for the subsequent two doses every 15 days (1:1 ratio
vol/vol of antigen/adjuvant). EPfs (extract obtained by sonication) was
used for immunization because it had no detergent, and it was the
most enriched with parasite material. Rabbits immunized with SPf66
vaccine were boosted six times. Bleeding of rabbits, previously
anesthetized with 10 mg/kg Ketamine Chlorhydrate, was carried out
before the first immunization and 10 days after the third dose.
Preparation of red blood cells (RBC): RBC antigen was obtained
with the same methodology for EPfd as described by SALCEDO et
al.37.
Immunogenicity and cross-reaction of An. albimanus and P.
falciparum extracts: The detection of specific anti-mosquito and anti-
Plasmodium rabbit antibodies was carried out by ELISA, as described
by ENGVALL & PERLMANN21 and by VOLLER et al.42, with a protein
concentration of 7 µg/well for the An. albimanus antigen (EAaF),
3 µg/well for the P. falciparum antigen (EPfs), and 1 µg/well for the
SPf66 vaccine. Additionally, the multiple antigen blot assay (MABA),
described by NOYA & ALARCÓN DE NOYA30, was used, sensitizing
the nitrocellulose membrane with protein (between five and
20 µg/mL). The immune sera were also evaluated by Immunoblotting40
at a dilution of 1:50 for anti-SPf66 vaccine and 1:100 for anti-female
mosquito (EAaF) and anti-P. falciparum (EPfs). The protein
concentration of the different antigenic preparations (EPfd, EPfs, EAaF,
and RBC) used for immunoblotting was 1.0 µg/µL. Anti-IgG rabbit
conjugated peroxidase was used at a 1:4000 dilution. A
chemiluminiscent substrate Luminol® was used (Amersham, ECL
Detection System). Strips were then exposed to a film (Hyperfilm®,
ECL Detection System, Amersham).
Statistical analysis: Statistical comparisons using median and
standard deviation were made. Three experiments were performed by
enzyme-linked immunosorbent assay (ELISA).
RESULTS
Electrophoretic pattern by SDS-PAGE: Silver stained An.
albimanus mosquito crude extracts revealed sixteen protein bands for
the female antigen (EAaF), ranging from 24 to 95 kDa. In the P.
falciparum preparation (EPfd), there were eighteen molecules between
26 to 161 kDa (data not shown).
Immunogenicity of An. albimanus female mosquitoes, P.
falciparum and SPf66 antigen preparations: Immune rabbit sera
against EPfs, SPf66 vaccine, or EAaF, evaluated by MABA are shown
in Fig. 1 and by ELISA in Fig. 2. Evaluations done by immunoblotting
are shown in Fig. 3.
Ten antigenic components were revealed in EAaF extract (apparent
molecular weight from 30 to 124 kDa) by anti-EAaF sera (Fig. 3).
Likewise, anti-EPfs sera recognized ten antigenic molecules between
12 to 143 kDa in EPfd (Fig. 3).
Cross-reaction by MABA: Rabbits immunized with EPfs
recognized the following antigens: excretory-secretory in the culture
supernatant of P. falciparum (Spt), EAaF, SPf66 vaccine, and normal
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RBC components (Fig. 1). Rabbits immunized with EAaF recognized
P. falciparum and SPf66 vaccine preparations (Fig. 1). Finally, rabbits
immunized with SPf66 vaccine recognized one or more components
in the culture supernatant of P. falciparum, EAaF, EPfs, and EPfd (Fig.
1). Noteworthy, only rabbit sera immunized with EPfs recognized RBC.
The rest of the sera groups did not react with this antigen preparation.
Cross-reaction of P. falciparum and An. albimanus by ELISA: A
reciprocal recognition was observed among the three extracts in rabbits
immunized with the heterologous antigens. The crude EAaF was
recognized by rabbit sera immunized with EPfs or SPf66, and similarly,
the crude EPfs was identified by anti-EAaF and anti-SPf66. Moreover,
the SPf66 vaccine was recognized by anti- EAaF and anti-EPfs antigen
immune sera (Fig. 2). Weak non-specific antibody responses were
observed with control rabbits immunized only with adjuvant.
Cross-reaction by immunoblotting: The anti-EAaF rabbit sera
recognized ten protein bands in the EPfd from 63 to 159 kDa,
specifically 68, 110, 136, and 159 kDa bands (Fig. 3). The anti-EPfs
reacted with fourteen protein bands in the EAaF between 25 and 160
kDa, ten of them being specifics with molecular weights of 25, 27, 36,
42, 44, 49, 83, 110, 118, and 160 kDa (Fig. 3). The anti-EPfs recognized
nine molecules: 32, 53, 65, 70, 74, 99, 118, 126, and 130 (duplet) kDa
in the RBC fraction (Fig. 3). Anti-SPf66 vaccine reacted with thirteen
protein bands in the EAaF ranging from 31 to 152 kDa, with only five
specific molecules: 31, 42, 44, 61, and 152 kDa (Fig. 3). The anti-
SPf66 rabbit recognized ten bands in EPfd, from 64 to 132 kDa. The
most specific molecules were: 70, 77, 82, 106, 110, and 127 kDa (Fig.
3). Some protein bands with molecular weights around 65, 74, 99 kDa
are also present in rabbits immunized only with CFA and IFA (data
not shown). These bands were excluded from analysis of specificity.
DISCUSSION
The Schistosoma-Biomphalaria association was the first host-
parasite model which demonstrated shared antigens8,22,43 . Different
molecules are cross-reactive and most of them have not been
characterized yet. Tropomyosin is one of the few molecules
characterized and it is shared by S. mansoni and B. glabrata20.
Since then, there are different epidemiological studies in which
the presence of cross-reactive antibodies were observed1,10,36. More
recently, the presence of two antigenic components from B. glabrata
were recognized by mice sera, immunized with a crude antigen from
S. mansoni adult worm (AWA), by immunoblotting13.
Other models in which antigenic sharing between parasites and
their intermediate hosts (snails) or vectors has been described: S.
haematobium, S. japonicum, and Paragonimus westermani, Leishmania
major and Phlebotomus duboscqi 9,27,28,33,39,43.
Fig. 1 - Immunogenicity and cross-reactivity of Plasmodium falciparum and Anopheles
albimanus crude extracts, evaluated by MABA. RBC: Red Blood Cells (1), EPf: extract of
RBC parasitized with P. falciparum treated with saponin detergent (2) and sonicated (3 and
4) with concentration of 5 µg/mL and 20 µg/mL respectively. Spt: Supernatant of culture P.
falciparum (5). SPf66: Vaccine anti-P. falciparum (6). EAaF: Extract of An. albimanus female
with concentration of: 20 µg/mL (7), 5 µg/mL (8) and 10 µg/mL (9), PBS (10). Preimmune
serum (a), Immune sera (b). Adj: Adjuvant. CC: Control of conjugate.
Fig. 2 - Immunogenicity (homologous sera) and antigen cross-reactivity (heterologous sera)
between P. falciparum and An. albimanus by ELISA. Rabbit’s sera immunized with: Extract
of An. albimanus female (EAaF) or Extract of P. falciparum by sonication (EPfs) or Vaccine
malaria (SPf66). Preimmune serum (a), Immune sera (b). Adj: Adjuvant. CC: Control of
conjugate. OD405: optical density at 405 nm. T: Standard deviation.
Fig. 3 - Pattern of antigenic recognition of An. albimanus female extract (EAaF), P. falciparum
treated with saponin (EPfd) and Red Blod Cell extract by rabbit sera: anti-EAaF, anti-EPfs
(P. falciparum treated by sonication) and anti-SPf66, by immunoblotting. Adj: Adjuvant,
CC: Conjugate Control, a: Pre-immune sera, b: Immune sera.
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The purpose of this study is to identify shared antigens in another
model: An. albimanus - P. falciparum.
Rabbits immunized with EPfs reacted strongly with the EAaF.
Furthermore, rabbits immunized with female An. albimanus extracts
recognized molecular components in only one of the two sonicated
EPf. This was expected, however, the protein concentrations were
different. The cross-recognition of possible common molecular
components between these two organisms was also confirmed by ELISA
and MABA assays. These anti-mosquito sera not only recognized
molecular components of the P. falciparum antigen, but unexpectedly,
also identified the SPf66 synthetic malaria vaccine, which contains
short sequences of four distinct surface molecules: one from the
sporozoite (NANP) and three from the asexual blood stages (83, 55,
33 kDa) of the parasite31,32. This findings deserves special attention
and further experiments will be required to evaluate the possible anti-
anopheline effect of this well-known protective vaccine31,32 .
Also, it would be interesting to identify the topography of the
antigens involved in the cross-reactivity in anophelines. A
complementary support of the cross-reactivity observed in this study
would be provided by cross-absorption of the antisera, with homologous
and heterologous antigens, before testing them against both antigens.
It was expected to find a major recognition of the molecular
components in the female mosquito extract because of the biochemical
complexity of the digestive system. However, the low recognition of
these molecules by the homologous or heterologous immune sera could
be attributed to different reasons. Firstly, the enriched proteases content
required for the digestion of the blood meal could cleave some proteins
during the preparation of the extract and it could inhibit the antigenicity
of them12. Although some extracts were prepared with protease
inhibitors, the results obtained in both cases were similar. Secondly, it
could be that proteases from the midgut and saliva of anophelines might
induce immune suppression in the immunized rabbits. In fact, it has
been demonstrated at the experimental level in the murine model, that
the initial secretion of IL-2 or γ-interferon by TH1 cells can be
suppressed by components present in the salivary gland extracts of
Aedes aegypti and Simulium vittatum mosquitoes14,15 .
Another possibility is that, the selection of an anti-IgG conjugate
might have occluded the response to other important isotypes (IgM
and IgE).
Moreover, the immunization with Complete and IFA adjuvants
could induce a predominantly TH1 response, which is not the habitual
immune reactivity to allergenic components of mosquito saliva. The
presence of specific IgE and IgG4 antibodies has been shown to be the
main serological response induced in mice, rabbits, and humans against
Aedes aegypti, Ae. communis and An. stephensi saliva6,7,34. Therefore,
it will be necessary to evaluate the presence of specific anti-mosquito
IgE and IgG4 antibodies as well.
In summary, the study of the shared antigens of any parasite-host
model should have three fundamental objectives: (i) In terms of
vaccines, the possibility to induce simultaneous protection against the
pathogenic agent and its vector; (ii) In terms of diagnosis, to eliminate
those molecules responsible for inespecificity of any immunoassay,
since exposure to the saliva of the vectors could be responsible for
some false positive serology, as we have observed already in persons
not exposed to malaria; (iii) In terms of parasite-host interactions, to
elucidate the possible role of common molecules involved in immune
evasion and immune modulation.
As far as we know, this is the first study to demonstrate sharing
antigens between Plasmodium and anopheline vectors. The results
presented herein not only could help to understand vector-parasite
interactions, but could also contribute to elucidate and to interpret
serological tests and immunoepidemiological data related to this
parasitic disease.
RESUMEN
Antígenos compartidos entre Plasmodium falciparum y
Anopheles albimanus
Epítopes de antígenos compartidos entre Plasmodium falciparum y
Anopheles albimanus fueron identificados. Diferentes grupos de conejos
fueron inmunizados con: extracto crudo de mosquito hembra de An.
albimanus (EAaH), glóbulos rojos infectados con P. falciparum (EPfs)
y la vacuna antimalárica sintética SPf66. Los anticuerpos policlonales
producidos en conejos fueron evaluados por ELISA, inmunoensayo
simultáneo de múltiples antígenos (MABA) e Immunoblotting. Todos
los extractos resultaron inmunogénicos cuando se evaluaron por ELISA,
MABA e Immunoblotting. Diez moléculas fueron identificadas en los
mosquitos hembras y diez en los antígenos de P. falciparum por los
sueros autólogos. El patrón electroforético por SDS-EGPA fue diferente
para los tres antígenos evaluados. La reactividad cruzada de moléculas
entre An. albimanus y P. falciparum fue demostrada por ELISA, MABA
e Immunoblotting. Anticuerpos anti-P. falciparum y anti-SPf66
reconocieron diez y cinco componentes respectivamente en el extracto
crudo de anofelinos (EAaH). Asimismo, sueros inmunes contra An.
albimanus hembra identificaron cuatro moléculas en el extracto del
antígeno de P. falciparum. Hasta el presente, este es el primer estudio en
el que se demuestra la presencia de antígenos compartidos entre
anofelinos y los parásitos de malaria. Este hallazgo podría ser de
relevancia para el diagnóstico, vacunas e interpretación de la
fisiopatología de la respuesta inmunitaria en malaria.
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